Registrieren
Registierung erfolgt in Kürze...
Details werden geladen...
Akebia Therapeutics Reports Second Quarter 2026 Financial Results and Business Highlights | The Manila Times
Q2 2026 Vafseo® (vadadustat) net product revenues grew to $21.3 million; more than 10,500 patients now on therapy
Ähnliche Seiten
Geron Corporation Reports Second Quarter 2026 Financial Results and Recent Business Highlights | The Manila Times
https://www.manilatimes.net/2026/08/05/tmt-newswire/globenewswire/geron-corporation-reports-second-quarter-2026-financial-results-and-recent-business-highlights/2398831Dyne Therapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights | The Manila Times
https://www.manilatimes.net/2026/07/30/tmt-newswire/globenewswire/dyne-therapeutics-reports-second-quarter-2026-financial-results-and-recent-business-highlights/2394460Aspen Aerogels, Inc. Reports Second Quarter 2026 Financial Results and Recent Business Highlights | The Manila Times
https://www.manilatimes.net/2026/08/06/tmt-newswire/globenewswire/aspen-aerogels-inc-reports-second-quarter-2026-financial-results-and-recent-business-highlights/2399833OnKure Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Highlights | The Manila Times
https://www.manilatimes.net/2026/08/05/tmt-newswire/globenewswire/onkure-therapeutics-reports-second-quarter-2026-financial-results-and-provides-business-highlights/2398429Gyre Therapeutics Reports Second Quarter 2026 and Year-to-Date Financial Results and Provides Business Update | The Manila Times
https://www.manilatimes.net/2026/08/07/tmt-newswire/globenewswire/gyre-therapeutics-reports-second-quarter-2026-and-year-to-date-financial-results-and-provides-business-update/2400915